Genesis IBRC India Stock Forecast for 2023 - 2025 - 2030
Updated on 05/12/2024
Genesis IBRC India Fair Value Forecast for 2023 - 2025 - 2030
Genesis IBRC India's Price has seen impressive growth In the last year, rising from 0.00 to 0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach 0.00 – an increase of 100.00%. For the next five years, the forecast is for Fair Value to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
BIOCON Stock Forecast | Biocon | Hold |
14
|
Rp304.00 | Buy/Sell | Rp270.86 | -12.83% |
524348 Stock Forecast | Aarti Drugs | Outperform |
16
|
Rp462.10 | Buy/Sell | Rp612.50 | 17.29% |
524669 Stock Forecast | Hester Biosciences | - |
15
|
Rp1.74k | Buy/Sell | Rp1.49k | -100.00% |
PANACEABIO Stock Forecast | Panacea Biotec | - |
7
|
Rp165.55 | Buy/Sell | Rp0.00 | -100.00% |
BETA Stock Forecast | Beta Drugs | - |
0
|
Rp1.43k | Buy/Sell | Rp0.00 | -100.00% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
532039 Stock Forecast | Zenotech Laboratories | - |
0
|
Rp63.46 | Buy/Sell | Rp0.00 | -100.00% |
524717 Stock Forecast | Titan Biotech | - |
0
|
Rp502.00 | Buy/Sell | Rp0.00 | -100.00% |
524663 Stock Forecast | Bharat Immunologicals & Biolog... | - |
0
|
Rp34.98 | Buy/Sell | Rp0.00 | -100.00% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
526139 Stock Forecast | Transgene Biotek | - |
0
|
Rp11.87 | Buy/Sell | Rp0.00 | -100.00% |
532041 Stock Forecast | Hindustan Bio Sciences | - |
0
|
Rp8.56 | Buy/Sell | Rp0.00 | -100.00% |
532871 Stock Forecast | Celestial Biolabs | - |
0
|
0.00 | Buy/Sell | 0.00 | 0.00% |
Genesis IBRC India EBIT Forecast for 2023 - 2025 - 2030
Genesis IBRC India's EBIT has seen growth In the last two years, going from -1.04M to -1.37M – a gain of 31.73% According to 0 analysts, Genesis IBRC India's EBIT will fall by 13.67% in the next year, reaching -1.18M. Professionals believe that By 2030, Genesis IBRC India's EBIT will fall to -1.18M – a 13.83% decrease from its current value.
Genesis IBRC India EPS Price Prediction Forecast for 2023 - 2025 - 2030
Genesis IBRC India's EPS has seen impressive growth In the last year, rising from 0.00 to 0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach 0.00 – an increase of 100.00%. For the next five years, the forecast is for EPS to grow by 100.00%.